首页096530 • KOSDAQ
add
Seegene Inc
昨日收盘价
₩25,700.00
当日价格范围
₩24,700.00 - ₩25,950.00
年度波幅
₩19,500.00 - ₩35,950.00
市值
1.30万亿 KRW
平均交易量
81.05万
市盈率
39.08
股息率
3.21%
主要交易所
KOSDAQ
市场资讯
财务信息
损益表
收入
净收入
| (KRW) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | 1088.24亿 | 18.43% |
经营支出 | 627.29亿 | -1.02% |
净收入 | 16.68亿 | 135.66% |
净利润率 | 1.53 | 130.06% |
每股收益 | — | — |
息税折旧摊销前利润 | 230.00亿 | 254.30% |
有效税率 | -43.11% | — |
资产负债表
总资产
负债总额
| (KRW) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 5355.99亿 | 1.06% |
总资产 | 1.25万亿 | -0.46% |
负债总额 | 2209.37亿 | 3.67% |
权益总额 | 1.03万亿 | — |
发行在外的股份 | 4618.71万 | — |
市净率 | 1.16 | — |
资产回报率 | 1.04% | — |
资本回报率 | 1.11% | — |
现金流
现金净变动
| (KRW) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | 16.68亿 | 135.66% |
来自运营的现金 | 426.60亿 | 112.61% |
投资现金 | -360.53亿 | -183.72% |
融资现金 | -168.27亿 | 8.76% |
现金净变动 | -151.18亿 | -132.44% |
自由现金流 | 260.78亿 | 78.22% |
简介
Seegene, Inc is a Korean manufacturer of in vitro diagnostic products, particularly molecular diagnostics. Its portfolio includes a range of assays and screening products for sepsis, respiratory diseases such as influenza and respiratory syncytial virus, as well as sexually transmitted infections. It was founded in 2000. In early 2020, it began developing and distributing a range of tests for SARS-CoV-2, the virus that causes COVID-19.
Along with its headquarters in Seoul, South Korea, the company has subsidiaries in the U.S., Canada, Germany, Italy, Mexico, Brazil, and the Middle East.
In September 2010, Seegene undertook a $16.6 million initial public offering to list on KOSDAQ, a trading board of Korea Exchange. Wikipedia
成立时间
2000年9月16日
员工数量
215
